ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 25 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,658,000 | -31.7% | 331,001 | -23.8% | 0.01% | 0.0% |
| Q1 2022 | $2,428,000 | +11.2% | 434,343 | +24.3% | 0.01% | +42.9% |
| Q4 2021 | $2,183,000 | -51.7% | 349,308 | -23.7% | 0.01% | -36.4% |
| Q3 2021 | $4,523,000 | -1.3% | 457,797 | -11.1% | 0.01% | +22.2% |
| Q2 2021 | $4,582,000 | -13.3% | 514,807 | +8.1% | 0.01% | -10.0% |
| Q1 2021 | $5,283,000 | +1535.6% | 476,414 | +1136.3% | 0.01% | +25.0% |
| Q4 2019 | $323,000 | – | 38,536 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Susquehanna International Group Ltd. | 12,326 | $19,475 | 0.01% |
| Compagnie Lombard Odier SCmA | 65,000 | $104,082 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $632 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 838 | $1,324 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,882 | $14,034 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $16,463 | 0.00% |
| MORGAN STANLEY | 44,156 | $69,766 | 0.00% |
| Citadel Advisors | 1,500 | $2,370 | 0.00% |
| Citadel Advisors | 4,900 | $7,742 | 0.00% |